Hysron and cushingoid Patient Reports February 12, 2012

Hysron Side Effects Report #4634371-8
Hysron side effect was reported by a Physician from on Mar 29, 2005. Female patient, 39 years of age, was diagnosed with breast cancer  and was treated with Hysron. After drug was administered, patient experienced the following side effects: cataract subcapsular, conjunctivitis, cushingoid, visual acuity reduced. Hysron dosage: 800 MG (400 MG, BID), ORAL; 600 MG DAILY, ORAL. During the same period patient was treated with SPIRONOLACTONE, PACLITAXEL, BUFFERIN, MITOMYCIN, FUTRAFUL, EPIRUBICIN, METHOTREXATE. Patient recovered.